Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-25 @ 1:45 AM
NCT ID:
NCT01860794
Brief Summary:
The purpose of clinical trials is to evaluate safety and tolerability of Fetal Mesencephalic Dopamine Neuronal Precursor Cells as a treatment for Patients with Parkinson's disease.
Detailed Description:
This study is phase I/II clinical trials which is accessible to those involved in the study and conducted by only Bundang CHA hospital.
The progress of the clinical trails is reported to and evaluated by Data monitoring committee before the enrolment of next human subject.
Study:
NCT01860794
Study Brief:
Protocol Section:
NCT01860794